{
  "id": 18177916,
  "title": "Biocryst outlines $415M-$425M 2026 operating expense guidance while keeping ORLADEYO at $625M-$645M",
  "url": "https://urgent.news/2026/11/04/biocryst-outlines-415m-425m-2026-operating-expense-guidance-while",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-04T20:36:47.000Z",
  "source": {
    "name": "Seeking Alpha News",
    "slug": "seeking-alpha-news",
    "url": "https://seekingalpha.com/news/4665473-biocryst-outlines-415m-425m-2026-operating-expense-guidance-while-keeping-orladeyo-at-625m?feed_item_type=news"
  },
  "original_language": "en",
  "account": null,
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}